<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35739067</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1539-6924</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Risk analysis : an official publication of the Society for Risk Analysis</Title><ISOAbbreviation>Risk Anal</ISOAbbreviation></Journal><ArticleTitle>Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan.</ArticleTitle><Pagination><StartPage>677</StartPage><EndPage>685</EndPage><MedlinePgn>677-685</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/risa.13982</ELocationID><Abstract><AbstractText>Since 2013, wild poliovirus (WPV) transmission occurred only for type 1 (WPV1). Following several years of increasing reported incidence (2017-2019) and programmatic disruptions caused by COVID-19 (early 2020), Pakistan and Afghanistan performed a large number of supplementary immunization activities (late 2020-2021). This increased intensity of immunization, following widespread transmission, substantially decreased WPV1 cases and positive environmental samples during 2021. Modeling the potential for undetected circulation of WPV1 after apparent interruption can support regional and global decisions about certification of the eradication of indigenous WPV1 transmission. We apply a stochastic model to estimate the confidence about no circulation (CNC) of WPV1 in Pakistan and Afghanistan as a function of time since the last reported case and/or positive environmental sample. Exploration of different assumptions about surveillance quality suggests a range for CNC for WPV1 as a function of time since the last positive surveillance signal, and supports the potential use of a time with no evidence of transmission of less than 3 years as sufficient to assume die out in the context of good acute flaccid paralysis (AFP) surveillance. We show high expected CNC based on AFP surveillance data alone, even with imperfect surveillance and some use of inactivated poliovirus vaccine masking the ability of AFP surveillance to detect transmission. Ensuring high quality AFP and environmental surveillance may substantially shorten the time required to reach high CNC. The time required for high CNC depends on whether immunization activities maintain high population immunity and the quality of surveillance data.</AbstractText><CopyrightInformation>&#xa9; 2022 Society for Risk Analysis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalkowska</LastName><ForeName>Dominika A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Kid Risk, Inc., Orlando, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badizadegan</LastName><ForeName>Kamran</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4900-9455</Identifier><AffiliationInfo><Affiliation>Kid Risk, Inc., Orlando, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Kimberly M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-0849-9147</Identifier><AffiliationInfo><Affiliation>Kid Risk, Inc., Orlando, Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NU2RGH001915</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NU2RGH001915</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Risk Anal</MedlineTA><NlmUniqueID>8109978</NlmUniqueID><ISSNLinking>0272-4332</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000346" MajorTopicYN="N" Type="Geographic">Afghanistan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Afghanistan</Keyword><Keyword MajorTopicYN="N">Pakistan</Keyword><Keyword MajorTopicYN="N">eradication</Keyword><Keyword MajorTopicYN="N">infection transmission modeling</Keyword><Keyword MajorTopicYN="N">polio</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35739067</ArticleId><ArticleId IdType="mid">NIHMS1822448</ArticleId><ArticleId IdType="pmc">PMC9780400</ArticleId><ArticleId IdType="doi">10.1111/risa.13982</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anis E, Kopel E, Singer S, Kaliner E, Moerman L, Moran-Gilad J, &#x2026; Grotto I (2013). Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveillance, 18(38), 20586.</Citation><ArticleIdList><ArticleId IdType="pubmed">24084337</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S, El Bassioni L, El Maamoon Nasr EM, Paananen A, Kaijalainen S, Asghar H, &#x2026; Roivainen M (2012). Detection of imported wild polioviruses and of vaccine-derived polioviruses by environmental surveillance in Egypt. Appl Environ Microbiol, 78(15), 5406&#x2013;5409. doi:10.1128/aem.00491-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aem.00491-12</ArticleId><ArticleId IdType="pmc">PMC3416427</ArticleId><ArticleId IdType="pubmed">22582070</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Kalkowska DA, &amp; Thompson KM (2019). Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission. BMJ Open, 9(1), e023938. doi:10.1136/bmjopen-2018-023938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-023938</ArticleId><ArticleId IdType="pmc">PMC6340450</ArticleId><ArticleId IdType="pubmed">30647038</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Ehrhardt DT, Farag NH, Hadler SC, &#x2026; Thompson KM (2018). Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in undervaccinated subpopulations. Risk Anal, 38(8), 1701&#x2013;1717. doi:10.1111/risa.12962</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.12962</ArticleId><ArticleId IdType="pmc">PMC7879700</ArticleId><ArticleId IdType="pubmed">29314143</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, &amp; Thompson KM (2009). Priority shifting and the dynamics of managing eradicable infectious disease. Management Science, 55(4), 650&#x2013;663.</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, &amp; Thompson KM (2017). Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers. Vaccine, 35(31), 3823&#x2013;3833. doi:10.1016/j.vaccine.2017.05.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.05.090</ArticleId><ArticleId IdType="pmc">PMC5488262</ArticleId><ArticleId IdType="pubmed">28606811</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, &amp; Thompson KM (2019). Evaluation of proactive and reactive proactive strategies for polio eradication activities in Pakistan and Afghanistan. Risk Anal, 39(2), 389&#x2013;401. doi:10.1111/risa.13194</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.13194</ArticleId><ArticleId IdType="pmc">PMC7857157</ArticleId><ArticleId IdType="pubmed">30239026</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Zimmermann M, Pallansch MA, &amp; Thompson KM (2017). Insights from a systematic search for information on designs, costs, and effectiveness of poliovirus environmental surveillance systems. Food Environ Virol, 9(4), 361&#x2013;382. doi:10.1007/s12560-017-9314-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-017-9314-4</ArticleId><ArticleId IdType="pmc">PMC7879701</ArticleId><ArticleId IdType="pubmed">28687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichner M, &amp; Hadeler KP (1995). Deterministic models for the eradication of poliomyelitis: vaccination with the inactivated (IPV) and attenuated (OPV) polio virus vaccine. Math Biosci, 127(2), 149&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">7795316</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SQ, Greening G, Baker M, Grimwood K, Hewitt J, Hulston D, &#x2026; Pallansch MA (2005). Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet, 366(9483), 394&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">16054940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Badizadegan K, &amp; Thompson KM (2022). Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan. Risk Anal, Submitted.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780402</ArticleId><ArticleId IdType="pubmed">35739080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, &#x2026; Thompson KM (2015). Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis, 211(11), 1800&#x2013;1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887763</ArticleId><ArticleId IdType="pubmed">25505296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SGF, &amp; Thompson KM (2015). Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination. BMC Infect Dis, 15, 66. doi:10.1186/s12879-015-0791-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0791-5</ArticleId><ArticleId IdType="pmc">PMC4344758</ArticleId><ArticleId IdType="pubmed">25886823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, &amp; Thompson KM (2019). Modeling undetected live poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan. Risk Anal, 39(2), 402&#x2013;413. doi:10.1111/risa.13214</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.13214</ArticleId><ArticleId IdType="pmc">PMC7842182</ArticleId><ArticleId IdType="pubmed">30296340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, &amp; Thompson KM (2019). Environmental surveillance system characteristics and impacts on confidence about no undetected serotype 1 wild poliovirus circulation. Risk Anal, 39(2), 414&#x2013;425. doi:10.1111/risa.13193</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.13193</ArticleId><ArticleId IdType="pmc">PMC7857156</ArticleId><ArticleId IdType="pubmed">30239023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Pallansch MA, Cochi SL, &amp; Thompson KM (2021). Updated characterization of poliovirus transmission in Pakistan and Afghanistan and the impacts of different outbreak response options. J Infect Dis, 224(9), 1529&#x2013;1538. doi:10.1093/infdis/jiab160</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab160</ArticleId><ArticleId IdType="pmc">PMC8083227</ArticleId><ArticleId IdType="pubmed">33885734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, &amp; Thompson KM (2021). Modeling undetected live poliovirus circulation after apparent interruption of transmission: Borno and Yobe in northeast Nigeria. Risk Anal, 41(2), 303&#x2013;311. doi:10.1111/risa.13486</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.13486</ArticleId><ArticleId IdType="pmc">PMC7814396</ArticleId><ArticleId IdType="pubmed">32348634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Wassilak SGF, Cochi SL, Pallansch MA, &amp; Thompson KM (2021). Global transmission of live polioviruses: Updated integrated dynamic modeling of the polio endgame. Risk Anal, 41(2), 248&#x2013;265. doi:10.1111/risa.13447</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.13447</ArticleId><ArticleId IdType="pmc">PMC7787008</ArticleId><ArticleId IdType="pubmed">31960533</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, &amp; Duintjer Tebbens RJ (2007). Eradication versus control for poliomyelitis: an economic analysis. Lancet, 369(9570), 1363&#x2013;1371. doi:10.1016/s0140-6736(07)60532-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(07)60532-7</ArticleId><ArticleId IdType="pubmed">17448822</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, &amp; Kalkowska DA (2020). Review of poliovirus modeling performed from 2000-2019 to support global polio eradication. Expert Rev Vaccines, 19(7), 661&#x2013;686. doi:10.1080/14760584.2020.1791093</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2020.1791093</ArticleId><ArticleId IdType="pmc">PMC7497282</ArticleId><ArticleId IdType="pubmed">32741232</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Kalkowska DA, &amp; Duintjer Tebbens RJ (2015). Managing population immunity to reduce or eliminate the risks of circulation following the importation of live polioviruses Vaccine, 33(3), 1568&#x2013;1577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907970</ArticleId><ArticleId IdType="pubmed">25701673</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. (2004). Report on the Second Meeting of the Regional Technical Advisory Group for Poliomyelitis Eradication. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/255054/who_em_pol_251_e_en.pdf</Citation></Reference><Reference><Citation>World Health Organization. (2013, 11
Nov 2013). Polio in the Syrian Arab Republic. Retrieved from http://polioeradication.org/news-post/polio-in-the-syrian-arab-republic/</Citation></Reference><Reference><Citation>World Health Organization. (2019a). Report from the Twentieth Meeting of the Global Commission for Certification of Poliomyelitis Eradication, Geneva, Switzerland, 17-18 October 2019. Retrieved from http://polioeradication.org/wp-content/uploads/2016/07/20th-meeting-of-the-Global-Commission-for-the-Certification-of-Eradication-of-Poliomyelitis-17-18-October-2019.pdf</Citation></Reference><Reference><Citation>World Health Organization. (2019b). Wild poliovirus type 1 - Iran (Islamic Republic of) Retrieved from https://www.who.int/emergencies/disease-outbreak-news/item/24-may-2019-wild-polio-virus-islamic-republic-of-iran-en</Citation></Reference><Reference><Citation>World Health Organization. (2020). Africa kicks out wild polio. Retrieved from https://polioeradication.org/news-post/africa-kicks-out-wild-polio/</Citation></Reference><Reference><Citation>World Health Organization. (2022). Wild poliovirus list: List of wild poliovirus by country and year. Retrieved from https://polioeradication.org/wp-content/uploads/2022/05/weekly-polio-analyses-WPV-20220517.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>